FDA's Neglect Endangers Children with Puberty Blockers
Submitted by MAGA
Posted 6 hours ago
**Alarm Bells Over FDA's Neglect of Puberty Blocker Safety**
In a shocking revelation, the Biden administration's FDA has ignored more than 70,000 reports of adverse events linked to puberty-blocking drugs, raising serious concerns about the agency's commitment to child safety.
As President Trump and Vice President Vance take the helm, they are faced with the urgent task of addressing the gaps in drug safety oversight that have persisted under the previous administration.
The recent findings highlight a clear failure to prioritize the health and safety of our youth, particularly regarding puberty blockers that are being prescribed off-label for gender transition in children.
Critics argue that the FDA's Drug Risk Monitoring Board, under previous leadership, systematically overlooked substantial evidence of harm associated with these drugs, which include severe adverse reactions such as strokes and lifelong disabilities.
While the agency has maintained a muted response to these alarming issues, it was swift to condemn other treatments like hydroxychloroquine for COVID-19, despite far fewer adverse events reported.
This stark contrast raises questions about the motivations behind the FDA's regulatory focus. The use of puberty blockers, initially developed for critical health conditions in adults, has thrived without adequate scrutiny, potentially jeopardizing the wellbeing of children under the guise of progressive medical practices.
Moreover, the reluctance to address the dangerous implications of these hormone treatments opens the door to further exploitation and confusion among children and their families.
The Trump administration's executive order on protecting children from chemical and surgical interventions marks a pivotal moment in rectifying these regulatory failures.
As the political tide turns, it will be crucial for the new administration to restore transparency and accountability within the FDA.
Parents across the nation deserve thorough investigations and clear guidelines based on science, not political agendas that jeopardize the health of our most vulnerable citizens.
It's time to stand up for our children and ensure that any medical interventions undergo rigorous safety evaluations before they are administered.
With a renewed focus on protecting the interests of American families, the Trump administration must act decisively to rectify the FDA's calculated negligence and prioritize the safety and wellbeing of our nation's youth.
Sources:
naturalnews.com
dailywire.com
naturalnews.com
In a shocking revelation, the Biden administration's FDA has ignored more than 70,000 reports of adverse events linked to puberty-blocking drugs, raising serious concerns about the agency's commitment to child safety.
As President Trump and Vice President Vance take the helm, they are faced with the urgent task of addressing the gaps in drug safety oversight that have persisted under the previous administration.
The recent findings highlight a clear failure to prioritize the health and safety of our youth, particularly regarding puberty blockers that are being prescribed off-label for gender transition in children.
Critics argue that the FDA's Drug Risk Monitoring Board, under previous leadership, systematically overlooked substantial evidence of harm associated with these drugs, which include severe adverse reactions such as strokes and lifelong disabilities.
While the agency has maintained a muted response to these alarming issues, it was swift to condemn other treatments like hydroxychloroquine for COVID-19, despite far fewer adverse events reported.
This stark contrast raises questions about the motivations behind the FDA's regulatory focus. The use of puberty blockers, initially developed for critical health conditions in adults, has thrived without adequate scrutiny, potentially jeopardizing the wellbeing of children under the guise of progressive medical practices.
Moreover, the reluctance to address the dangerous implications of these hormone treatments opens the door to further exploitation and confusion among children and their families.
The Trump administration's executive order on protecting children from chemical and surgical interventions marks a pivotal moment in rectifying these regulatory failures.
As the political tide turns, it will be crucial for the new administration to restore transparency and accountability within the FDA.
Parents across the nation deserve thorough investigations and clear guidelines based on science, not political agendas that jeopardize the health of our most vulnerable citizens.
It's time to stand up for our children and ensure that any medical interventions undergo rigorous safety evaluations before they are administered.
With a renewed focus on protecting the interests of American families, the Trump administration must act decisively to rectify the FDA's calculated negligence and prioritize the safety and wellbeing of our nation's youth.
Sources:
naturalnews.com
dailywire.com
naturalnews.com
Latest News